Global Inactivated Poliovirus Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Inactivated Poliovirus Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Inactivated Poliovirus Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Inactivated Poliovirus Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Inactivated Poliovirus Vaccine Segment by Type

2.2.1 Human Diploid Cell

2.2.2 Monkey Kidney Cell

2.3 Inactivated Poliovirus Vaccine Sales by Type

2.3.1 Global Inactivated Poliovirus Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Inactivated Poliovirus Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Inactivated Poliovirus Vaccine Sale Price by Type (2017-2022)

2.4 Inactivated Poliovirus Vaccine Segment by Application

2.4.1 Public

2.4.2 Private

2.5 Inactivated Poliovirus Vaccine Sales by Application

2.5.1 Global Inactivated Poliovirus Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Inactivated Poliovirus Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Inactivated Poliovirus Vaccine Sale Price by Application (2017-2022)

3 Global Inactivated Poliovirus Vaccine by Company

3.1 Global Inactivated Poliovirus Vaccine Breakdown Data by Company

3.1.1 Global Inactivated Poliovirus Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Inactivated Poliovirus Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Inactivated Poliovirus Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Inactivated Poliovirus Vaccine Revenue by Company (2020-2022)

3.2.2 Global Inactivated Poliovirus Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Inactivated Poliovirus Vaccine Sale Price by Company

3.4 Key Manufacturers Inactivated Poliovirus Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Inactivated Poliovirus Vaccine Product Location Distribution

3.4.2 Players Inactivated Poliovirus Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Inactivated Poliovirus Vaccine by Geographic Region

4.1 World Historic Inactivated Poliovirus Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Inactivated Poliovirus Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Inactivated Poliovirus Vaccine Annual Revenue by Geographic Region

4.2 World Historic Inactivated Poliovirus Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Inactivated Poliovirus Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Inactivated Poliovirus Vaccine Annual Revenue by Country/Region

4.3 Americas Inactivated Poliovirus Vaccine Sales Growth

4.4 APAC Inactivated Poliovirus Vaccine Sales Growth

4.5 Europe Inactivated Poliovirus Vaccine Sales Growth

4.6 Middle East & Africa Inactivated Poliovirus Vaccine Sales Growth

5 Americas

5.1 Americas Inactivated Poliovirus Vaccine Sales by Country

5.1.1 Americas Inactivated Poliovirus Vaccine Sales by Country (2017-2022)

5.1.2 Americas Inactivated Poliovirus Vaccine Revenue by Country (2017-2022)

5.2 Americas Inactivated Poliovirus Vaccine Sales by Type

5.3 Americas Inactivated Poliovirus Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Inactivated Poliovirus Vaccine Sales by Region

6.1.1 APAC Inactivated Poliovirus Vaccine Sales by Region (2017-2022)

6.1.2 APAC Inactivated Poliovirus Vaccine Revenue by Region (2017-2022)

6.2 APAC Inactivated Poliovirus Vaccine Sales by Type

6.3 APAC Inactivated Poliovirus Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Inactivated Poliovirus Vaccine by Country

7.1.1 Europe Inactivated Poliovirus Vaccine Sales by Country (2017-2022)

7.1.2 Europe Inactivated Poliovirus Vaccine Revenue by Country (2017-2022)

7.2 Europe Inactivated Poliovirus Vaccine Sales by Type

7.3 Europe Inactivated Poliovirus Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Inactivated Poliovirus Vaccine by Country

8.1.1 Middle East & Africa Inactivated Poliovirus Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Inactivated Poliovirus Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Inactivated Poliovirus Vaccine Sales by Type

8.3 Middle East & Africa Inactivated Poliovirus Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Inactivated Poliovirus Vaccine

10.3 Manufacturing Process Analysis of Inactivated Poliovirus Vaccine

10.4 Industry Chain Structure of Inactivated Poliovirus Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Inactivated Poliovirus Vaccine Distributors

11.3 Inactivated Poliovirus Vaccine Customer

12 World Forecast Review for Inactivated Poliovirus Vaccine by Geographic Region

12.1 Global Inactivated Poliovirus Vaccine Market Size Forecast by Region

12.1.1 Global Inactivated Poliovirus Vaccine Forecast by Region (2023-2028)

12.1.2 Global Inactivated Poliovirus Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Inactivated Poliovirus Vaccine Forecast by Type

12.7 Global Inactivated Poliovirus Vaccine Forecast by Application

13 Key Players Analysis

13.1 Sanofi

13.1.1 Sanofi Company Information

13.1.2 Sanofi Inactivated Poliovirus Vaccine Product Offered

13.1.3 Sanofi Inactivated Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Main Business Overview

13.1.5 Sanofi Latest Developments

13.2 GSK

13.2.1 GSK Company Information

13.2.2 GSK Inactivated Poliovirus Vaccine Product Offered

13.2.3 GSK Inactivated Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GSK Main Business Overview

13.2.5 GSK Latest Developments

13.3 Serum Institute (Bilthoven Biologicals)

13.3.1 Serum Institute (Bilthoven Biologicals) Company Information

13.3.2 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Product Offered

13.3.3 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Serum Institute (Bilthoven Biologicals) Main Business Overview

13.3.5 Serum Institute (Bilthoven Biologicals) Latest Developments

13.4 IMBCA

13.4.1 IMBCA Company Information

13.4.2 IMBCA Inactivated Poliovirus Vaccine Product Offered

13.4.3 IMBCA Inactivated Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 IMBCA Main Business Overview

13.4.5 IMBCA Latest Developments

14 Research Findings and Conclusion

Table 1. Inactivated Poliovirus Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Inactivated Poliovirus Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Human Diploid Cell

Table 4. Major Players of Monkey Kidney Cell

Table 5. Global Inactivated Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)

Table 6. Global Inactivated Poliovirus Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Inactivated Poliovirus Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Inactivated Poliovirus Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Inactivated Poliovirus Vaccine Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Inactivated Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)

Table 11. Global Inactivated Poliovirus Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Inactivated Poliovirus Vaccine Revenue by Application (2017-2022)

Table 13. Global Inactivated Poliovirus Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Inactivated Poliovirus Vaccine Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Inactivated Poliovirus Vaccine Sales by Company (2020-2022) & (K Units)

Table 16. Global Inactivated Poliovirus Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Inactivated Poliovirus Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Inactivated Poliovirus Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Inactivated Poliovirus Vaccine Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Inactivated Poliovirus Vaccine Producing Area Distribution and Sales Area

Table 21. Players Inactivated Poliovirus Vaccine Products Offered

Table 22. Inactivated Poliovirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Inactivated Poliovirus Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Inactivated Poliovirus Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Inactivated Poliovirus Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Inactivated Poliovirus Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Inactivated Poliovirus Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Inactivated Poliovirus Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Inactivated Poliovirus Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Inactivated Poliovirus Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Inactivated Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)

Table 34. Americas Inactivated Poliovirus Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Inactivated Poliovirus Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Inactivated Poliovirus Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Inactivated Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)

Table 38. Americas Inactivated Poliovirus Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Inactivated Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)

Table 40. Americas Inactivated Poliovirus Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Inactivated Poliovirus Vaccine Sales by Region (2017-2022) & (K Units)

Table 42. APAC Inactivated Poliovirus Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Inactivated Poliovirus Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Inactivated Poliovirus Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Inactivated Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)

Table 46. APAC Inactivated Poliovirus Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Inactivated Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)

Table 48. APAC Inactivated Poliovirus Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Inactivated Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)

Table 50. Europe Inactivated Poliovirus Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Inactivated Poliovirus Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Inactivated Poliovirus Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Inactivated Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)

Table 54. Europe Inactivated Poliovirus Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Inactivated Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)

Table 56. Europe Inactivated Poliovirus Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Inactivated Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Inactivated Poliovirus Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Inactivated Poliovirus Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Inactivated Poliovirus Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Inactivated Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Inactivated Poliovirus Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Inactivated Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Inactivated Poliovirus Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Inactivated Poliovirus Vaccine

Table 66. Key Market Challenges & Risks of Inactivated Poliovirus Vaccine

Table 67. Key Industry Trends of Inactivated Poliovirus Vaccine

Table 68. Inactivated Poliovirus Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Inactivated Poliovirus Vaccine Distributors List

Table 71. Inactivated Poliovirus Vaccine Customer List

Table 72. Global Inactivated Poliovirus Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Inactivated Poliovirus Vaccine Sales Market Forecast by Region

Table 74. Global Inactivated Poliovirus Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Inactivated Poliovirus Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Inactivated Poliovirus Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Inactivated Poliovirus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Inactivated Poliovirus Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Inactivated Poliovirus Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Inactivated Poliovirus Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Inactivated Poliovirus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Inactivated Poliovirus Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Inactivated Poliovirus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Inactivated Poliovirus Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Inactivated Poliovirus Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Inactivated Poliovirus Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Inactivated Poliovirus Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Inactivated Poliovirus Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Inactivated Poliovirus Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Inactivated Poliovirus Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Inactivated Poliovirus Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Sanofi Basic Information, Inactivated Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Sanofi Inactivated Poliovirus Vaccine Product Offered

Table 94. Sanofi Inactivated Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Sanofi Main Business

Table 96. Sanofi Latest Developments

Table 97. GSK Basic Information, Inactivated Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. GSK Inactivated Poliovirus Vaccine Product Offered

Table 99. GSK Inactivated Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. GSK Main Business

Table 101. GSK Latest Developments

Table 102. Serum Institute (Bilthoven Biologicals) Basic Information, Inactivated Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Product Offered

Table 104. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Serum Institute (Bilthoven Biologicals) Main Business

Table 106. Serum Institute (Bilthoven Biologicals) Latest Developments

Table 107. IMBCA Basic Information, Inactivated Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. IMBCA Inactivated Poliovirus Vaccine Product Offered

Table 109. IMBCA Inactivated Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. IMBCA Main Business

Table 111. IMBCA Latest Developments

List of Figures

Figure 1. Picture of Inactivated Poliovirus Vaccine

Figure 2. Inactivated Poliovirus Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Inactivated Poliovirus Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Inactivated Poliovirus Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Inactivated Poliovirus Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Human Diploid Cell

Figure 10. Product Picture of Monkey Kidney Cell

Figure 11. Global Inactivated Poliovirus Vaccine Sales Market Share by Type in 2021

Figure 12. Global Inactivated Poliovirus Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Inactivated Poliovirus Vaccine Consumed in Public

Figure 14. Global Inactivated Poliovirus Vaccine Market: Public (2017-2022) & (K Units)

Figure 15. Inactivated Poliovirus Vaccine Consumed in Private

Figure 16. Global Inactivated Poliovirus Vaccine Market: Private (2017-2022) & (K Units)

Figure 17. Global Inactivated Poliovirus Vaccine Sales Market Share by Application (2017-2022)

Figure 18. Global Inactivated Poliovirus Vaccine Revenue Market Share by Application in 2021

Figure 19. Inactivated Poliovirus Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Inactivated Poliovirus Vaccine Revenue Market Share by Company in 2021

Figure 21. Global Inactivated Poliovirus Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Inactivated Poliovirus Vaccine Revenue Market Share by Geographic Region in 2021

Figure 23. Global Inactivated Poliovirus Vaccine Sales Market Share by Region (2017-2022)

Figure 24. Global Inactivated Poliovirus Vaccine Revenue Market Share by Country/Region in 2021

Figure 25. Americas Inactivated Poliovirus Vaccine Sales 2017-2022 (K Units)

Figure 26. Americas Inactivated Poliovirus Vaccine Revenue 2017-2022 ($ Millions)

Figure 27. APAC Inactivated Poliovirus Vaccine Sales 2017-2022 (K Units)

Figure 28. APAC Inactivated Poliovirus Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. Europe Inactivated Poliovirus Vaccine Sales 2017-2022 (K Units)

Figure 30. Europe Inactivated Poliovirus Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Inactivated Poliovirus Vaccine Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Inactivated Poliovirus Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Americas Inactivated Poliovirus Vaccine Sales Market Share by Country in 2021

Figure 34. Americas Inactivated Poliovirus Vaccine Revenue Market Share by Country in 2021

Figure 35. United States Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Inactivated Poliovirus Vaccine Sales Market Share by Region in 2021

Figure 40. APAC Inactivated Poliovirus Vaccine Revenue Market Share by Regions in 2021

Figure 41. China Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Inactivated Poliovirus Vaccine Sales Market Share by Country in 2021

Figure 48. Europe Inactivated Poliovirus Vaccine Revenue Market Share by Country in 2021

Figure 49. Germany Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Inactivated Poliovirus Vaccine Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Inactivated Poliovirus Vaccine Revenue Market Share by Country in 2021

Figure 56. Egypt Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Inactivated Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Inactivated Poliovirus Vaccine in 2021

Figure 62. Manufacturing Process Analysis of Inactivated Poliovirus Vaccine

Figure 63. Industry Chain Structure of Inactivated Poliovirus Vaccine

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles